Search results
FIIs hit sell button on 9 Adani stocks but LIC bullish on 2 underdogs
The Economic Times· 2 hours agoAdani Energy and Adani Enterprises. An analysis of shareholding pattern of all 10 Adani stocks shows...
Mankind Pharma acquires Bharat Serums and Vaccines for Rs 13,600 crore
Business Standard India· 11 hours agoMankind Pharma on Thursday said it has entered into a definitive agreement to acquire a 100 per cent...
George Weiss Offers to Fund Wind-Down of Hedge Fund He Founded
Livemint· 11 hours agoThe hedge fund filed for Chapter 11 in April after announcing it would shut down and return cash. Weiss is also involved in a legal dispute with creditor Jefferies Financial ...
Mankind Pharma trumps EQT-ADIA, set to acquire BSV for Rs 14,000 crore - ET HealthWorld | Pharma
The Economic Times· 20 hours agoMumbai: Mankind Pharma, India’s fourth largest pharma company by market share, is all set to acquire...
In data: JP Morgan, Houlihan Lokey top H1 2024 M&A financial advisor list
Just Style· 21 hours agoGlobalData's Deals Database shows finance firm JP Morgan secured the top spot in deal value by...
Biogen, Sage tremor drug fails key trial
BioPharma Dive· 2 days ago"Stepping back — we’re not sure what to get excited about at the moment," wrote Jefferies analyst Akash Tewari, who has a "Hold" rating on Sage....
Reckitt signals baby-formula exit as strategic review launched
Just Food· 2 days agoAt the time, Barclays suggested there could be around 400 other cases pending in the US. Reckitt...
Singapore Telecom: 3G service Phase-Out Begins In Aug 2024, Starting With M1 Mobile Network
Free Press Journal· 2 days agoThe phase-out of 3G telecom services in Singapore — and the transition to 4G/5G — begins from August...
Budget 2024 Impact: Jewellery stocks continue to shine for 2nd day on customs duty cut; Kalyan...
Livemint· 2 days agoJewellery stocks continued their upward trend for the second consecutive day on Wednesday as...
Top 5 medtech deals in the first half of 2024
MedTech Dive· 2 days agoThe first six months of the year brought a series of multibillion-dollar deals, led by Johnson & Johnson’s $13.1 billion takeover of Shockwave Medical.
